Welcome to our dedicated page for NewAge news (Ticker: NBEV), a resource for investors and traders seeking the latest updates and insights on NewAge stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NewAge's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NewAge's position in the market.
NewAge, Inc. (NASDAQ: NBEV) has won a Gold award for its ‘NewAge Tips’ Onboarding Video Series at the 2021 Viddy Awards, recognizing excellence in digital video. The company also received two honorable mentions for ‘John Wadsworth: Superfood Revolution’ Mini Docuseries. The Viddy Awards, administered by the Association of Marketing and Communication Professionals, highlight achievements in video production. NewAge's approach to onboarding emphasizes fun, gamification, and social-first tactics to support Brand Partners in their business efforts.
NewAge, Inc. (Nasdaq: NBEV) announced Ed Brennan as the new Chairman of the Board, effective January 1, 2022, succeeding Gregory Fea, who held the position since 2018. Fea will remain a Board member post-transition. Brennan, a Board member since 2017, has extensive leadership experience, including roles at Duty Free Shoppers and the Miller Family Office. Under Fea's tenure, NewAge grew from $25 million in revenue in 2016 to over $400 million today, highlighting significant growth during his leadership.
NewAge, Inc. (Nasdaq: NBEV) has announced the appointment of Judith Hammerschmidt to its Board of Directors. Hammerschmidt brings over 30 years of corporate law experience, specifically in highly regulated industries such as nutritional supplements. CEO Brent Willis expressed optimism about her contributions to the company's growth strategy. Hammerschmidt previously served as Executive VP and International Chief Counsel for Herbalife and currently holds a board position at Verb Technology Company. NewAge focuses on D2C organic products and operates in over 50 countries.
NewAge (Nasdaq: NBEV) announced participation in the 10th Annual Roth Capital Deer Valley Conference on December 9-10, 2021, at the Montage Hotel in Park City, UT. CEO Brent Willis and CFO Kevin Manion will conduct one-on-one meetings with investors during the event. NewAge focuses on direct-to-consumer (D2C) organic products promoting a healthy lifestyle, with a presence in over 50 countries across health and wellness, beauty, and nutritional performance sectors. For more information, visit NewAgeGroup.com.
NewAge (Nasdaq: NBEV) has announced a groundbreaking discovery related to aging and cardiovascular health, recently filing a patent for a new method that enhances the natural secretion of human growth hormone (HGH). This innovation reportedly blocks the action of dipeptidyl-peptidase 4 (DPP4), allowing for a 99.1% improvement in hormonal signaling. The result is a potential product that could positively affect energy levels, muscle mass, and overall cellular health. NewAge positions this development as a significant advancement in combating age-related decline.
NewAge, Inc. (NBEV) reported a strong 59% year-over-year increase in net revenue to $100 million for Q3 2021, up from $63 million in Q3 2020. Gross profit rose significantly by $29 million to $66 million, with gross margin improving to 66.3%. Despite a net loss of $2.7 million, a notable improvement from $14.1 million in the previous year, adjusted EBITDA also showed progress, narrowing to a loss of $4.4 million. The company emphasized its growth strategies and resilience amid supply chain challenges, supported by a robust balance sheet with $62.3 million in cash.
NewAge, Inc. (NBEV) has appointed Jennifer Grafton as Senior Vice President and General Counsel, bringing 16 years of corporate counsel experience. Grafton, who previously held roles at E2open Parent Holdings and Westmoreland Companies, will focus on SEC compliance, corporate governance, and M&A transactions. CEO Brent Willis expressed confidence in her ability to support the company's growth and best practices. Grafton is enthusiastic about joining NewAge at a pivotal moment and leveraging her expertise in the half-a-billion-dollar start-up.
NewAge, Inc. (Nasdaq: NBEV) announced the expansion of its Lucim+ skincare line with two new products: Lucim+ Volumizing Eyelash Serum and Lucim+ Lip Plumping Gloss. Developed via a crowdsourcing approach, these products provide safe, clinically tested alternatives to popular beauty treatments. The eyelash serum promises fuller, longer lashes in four weeks, while the lip gloss instantly enhances lip volume. With the clean and natural beauty product market projected to reach $54 billion by 2027, NewAge aims to capitalize on the growing demand for safe beauty products. Both items received the Good Face Seal of Approval.
NewAge, Inc. (Nasdaq: NBEV), a direct-to-consumer company focused on organic and healthy products, will release its third-quarter financial results for the period ending September 30, 2021, on November 9, 2021, after market close. A conference call for analysts and investors is scheduled for the same day at 5:00 p.m. ET to discuss the results. The company operates in over 75 countries and offers a diverse portfolio across health, beauty, and nutritional categories through a network of over 400,000 independent Brand Partners.
